LUXHT
Index Performance
Overview
Description
The coming years will welcome a new breed of historically important, publicly listed healthcare technology companies that more closely resemble the tech mega-caps of today, with platform-based innovation, highly scalable business models, network effects, high impact, and high value creation. Technologies such as teleoperated devices, wearable sensors, and machine learning and artificial intelligence are arming patients and healthcare providers with tools to make better and quicker clinical decisions. The intersection of healthcare and technology has the potential to transform everything from how patients interact with care providers, to how diagnostic data is obtained and analyzed, from the ways interventions are recommended to the ways outcomes are measured. Developed by Lux Capital, the Lux Health + Tech Index™ recognizes the life-changing power of healthcare + technology.
Full methodology- TickerLUXHT
- Inception Date04/27/2021
- WeightingCustom
- # of holdings44
What's inside?
Holdings
All holdings as of July 26, 2024
| Oscar Health, Inc. (OSCR) | 11.59% | $3.09B | 45.77% | N/A | 0.71 |
| Natera, Inc. (NTRA) | 6.03% | $12.54B | 52.11% | 56.72% | 8.78 |
| Hims & Hers Health, Inc. (HIMS) | 5.68% | $4.80B | 45.81% | 68.43% | 3.50 |
| GoodRx Holdings, Inc. (GDRX) | 4.78% | $824.49M | 7.55% | 85.64% | 3.86 |
| Clover Health Investments Corp. (CLOV) | 3.99% | $667.13M | -34.36% | N/A | 0.21 |
| Myriad Genetics, Inc. (MYGN) | 3.07% | $2.52B | 11.59% | 62.71% | 2.53 |
| Intuitive Surgical, Inc. (ISRG) | 3.04% | $155.20B | 14.47% | 68.30% | 20.59 |
| Align Technology, Inc. (ALGN) | 2.87% | $17.02B | 2.63% | 70.65% | 4.43 |
| Guardant Health, Inc. (GH) | 2.75% | $3.91B | 30.90% | 61.25% | 4.52 |
| NeoGenomics, Inc. (NEO) | 2.74% | $1.93B | 13.86% | 39.69% | 3.61 |
| Axonics, Inc. (AXNX) | 2.64% | $3.48B | 29.38% | 73.30% | 8.30 |
| Lifestance Health Group, Inc. (LFST) | 2.63% | $2.12B | 18.94% | 24.02% | 2.52 |
| Hologic, Inc. (HOLX) | 2.51% | $18.18B | -0.85% | 55.27% | 4.77 |
| IQVIA Holdings, Inc. (IQV) | 2.41% | $42.35B | 2.53% | 27.71% | 3.35 |
| EXACT Sciences Corp. (EXAS) | 2.40% | $8.92B | 5.82% | 69.66% | 5.73 |
| Veeva Systems, Inc. (VEEV) | 2.40% | $30.16B | 23.56% | 73.26% | 11.23 |
| Schrödinger, Inc. (SDGR) | 2.26% | $1.42B | -43.51% | 51.61% | 8.71 |
| CareDx, Inc. (CDNA) | 2.18% | $982.82M | -6.75% | 63.13% | 1.32 |
| Health Catalyst, Inc. (HCAT) | 2.05% | $459.88M | 1.16% | 34.92% | 1.22 |
| iRhythm Technologies, Inc. (IRTC) | 1.99% | $2.95B | 18.39% | 66.34% | 7.34 |
| Fulgent Genetics, Inc. (FLGT) | 1.99% | $687.96M | -2.54% | 31.19% | 1.22 |
| Veracyte, Inc. (VCYT) | 1.94% | $1.82B | 17.50% | 62.50% | 3.89 |
| Twist Bioscience Corp. (TWST) | 1.90% | $3.35B | 25.13% | 41.01% | 6.41 |
| Progyny, Inc. (PGNY) | 1.89% | $2.72B | 7.62% | 22.44% | 3.16 |
| PROCEPT BioRobotics Corp. (PRCT) | 1.65% | $3.31B | 82.51% | 53.55% | 15.20 |
| Globus Medical, Inc. (GMED) | 1.61% | $8.08B | 119.26% | 55.30% | 3.87 |
| Tandem Diabetes Care, Inc. (TNDM) | 1.60% | $2.63B | 13.16% | 49.39% | 3.02 |
| Inspire Medical Systems, Inc. (INSP) | 1.53% | $4.01B | 28.24% | 84.91% | 8.99 |
| Definitive Healthcare Corp. (DH) | 1.52% | $702.89M | 7.23% | 64.68% | 4.89 |
| Accolade, Inc. (ACCD) | 1.34% | $308.03M | 18.49% | 37.53% | 1.30 |
| ResMed, Inc. (RMD) | 1.32% | $30.61B | 7.17% | 56.94% | 6.57 |
| Castle Biosciences, Inc. (CSTL) | 1.19% | $533.09M | 73.59% | 77.28% | 1.57 |
| Doximity, Inc. (DOCS) | 1.19% | $3.51B | 13.45% | 89.34% | 10.07 |
| DexCom, Inc. (DXCM) | 1.18% | $42.89B | 15.26% | 62.40% | N/A |
| Adaptive Biotechnologies Corp. (ADPT) | 1.09% | $638.10M | 11.23% | 50.35% | 2.22 |
| Masimo Corp. (MASI) | 1.07% | $5.84B | -12.78% | 49.05% | 4.43 |
| Illumina, Inc. (ILMN) | 1.06% | $18.69B | -1.01% | 61.99% | 5.12 |
| Teladoc Health, Inc. (TDOC) | 1.06% | $1.57B | 2.68% | 54.74% | 1.15 |
| Insulet Corp. (PODD) | 1.05% | $13.37B | 23.35% | 70.16% | 7.46 |
| 10X Genomics, Inc. (TXG) | 0.87% | $2.10B | 5.01% | 67.78% | 6.72 |
| Cytek Biosciences, Inc. (CTKB) | 0.83% | $853.27M | 20.96% | 51.30% | 3.11 |
| Pacific Biosciences of California, Inc. (PACB) | 0.56% | $518.84M | -0.23% | 11.41% | 6.89 |
| Nevro Corp. (NVRO) | 0.52% | $362.88M | 5.78% | 66.30% | 1.09 |
| GRAIL, Inc. (GRAL) | 0.02% | $457.97M | 36.03% | -81.99% | N/A |
